Keywords: novartis, invests, million, swiss, francs, france, produce

Novartis invests 136 million Swiss francs in France to produce anti-IgE

Article | 19 January 2000

Print This

Novartis says that it has chosen Huningue in Alsace, France, as thelocation for its future production of anti-IgE (rhuMAb-E25), a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in